- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vivanza Biosciences Limited has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The consolidated figures show total income from operations at ₹52.91 lakh for the quarter and ₹2,788.91 lakh for the year. The company reported a net loss after tax of ₹99.81 lakh for the quarter and ₹67.41 lakh for the year. Earnings per share stood at a negative ₹0.17 for the year. The standalone results mirror these trends, with a loss after tax of ₹96.54 lakh for the quarter and ₹69.51 lakh for the year, on total income of ₹18.89 lakh for the quarter and ₹1,446.73 lakh for the year. These results reflect ongoing challenges impacting profitability.